{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T01:18:26Z","timestamp":1782523106153,"version":"3.54.5"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["NRF-2019R1I1A1A01059454"],"award-info":[{"award-number":["NRF-2019R1I1A1A01059454"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008005","name":"Yonsei University College of Medicine","doi-asserted-by":"publisher","award":["NRF-2019R1I1A1A01059454"],"award-info":[{"award-number":["NRF-2019R1I1A1A01059454"]}],"id":[{"id":"10.13039\/501100008005","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurobiology of Aging"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1016\/j.neurobiolaging.2021.06.004","type":"journal-article","created":{"date-parts":[[2021,6,12]],"date-time":"2021-06-12T11:13:34Z","timestamp":1623496414000},"page":"45-54","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["Apolipoprotein E4, amyloid, and cognition in Alzheimer's and Lewy body disease"],"prefix":"10.1016","volume":"106","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1431-2975","authenticated-orcid":false,"given":"Jin Ho","family":"Jung","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2817-3352","authenticated-orcid":false,"given":"Seun","family":"Jeon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyoungwon","family":"Baik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang Hyun","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seok Jong","family":"Chung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han Soo","family":"Yoo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seong Ho","family":"Jeong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young H.","family":"Sohn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phil Hyu","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0187-8440","authenticated-orcid":false,"given":"Byoung Seok","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.neurobiolaging.2021.06.004_bib0001","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.3346\/jkms.2010.25.7.1071","article-title":"Seoul Neuropsychological Screening Battery-dementia version (SNSB-D): a useful tool for assessing and monitoring cognitive impairments in dementia patients","volume":"25","author":"Ahn","year":"2010","journal-title":"J Korean Med Sci"},{"issue":"3","key":"10.1016\/j.neurobiolaging.2021.06.004_bib0002","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.jalz.2011.03.008","article-title":"The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease","volume":"7","author":"Albert","year":"2011","journal-title":"Alzheimers Dement"},{"issue":"23","key":"10.1016\/j.neurobiolaging.2021.06.004_bib0003","doi-asserted-by":"crossref","first-page":"6139","DOI":"10.1093\/hmg\/ddu334","article-title":"Genetic analysis implicates APOE, SNCA and suggests lysosomal dysfunction in the etiology of dementia with Lewy bodies","volume":"23","author":"Bras","year":"2014","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.neurobiolaging.2021.06.004_bib0004","doi-asserted-by":"crossref","unstructured":"Brecht, W.J., Harris, F.M., Chang, S., Tesseur, I., Yu, G.-Q., Xu, Q., Dee Fish, J., Wyss-Coray, T., Buttini, M., Mucke, L., Mahley, R.W., Huang, Y., 2004. Neuron-specific apolipoprotein E4 proteolysis is associated with increased tau phosphorylation in brains of transgenic mice. J Neurosci. 24(10), 2527-2534.","DOI":"10.1523\/JNEUROSCI.4315-03.2004"},{"issue":"1","key":"10.1016\/j.neurobiolaging.2021.06.004_bib0005","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1212\/WNL.0b013e3181c7da8e","article-title":"In vivo amyloid imaging in autopsy-confirmed Parkinson disease with dementia","volume":"74","author":"Burack","year":"2010","journal-title":"Neurology"},{"issue":"6","key":"10.1016\/j.neurobiolaging.2021.06.004_bib0006","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1093\/brain\/awr089","article-title":"Assessment of mild dementia with amyloid and dopamine terminal positron emission tomography","volume":"134","author":"Burke","year":"2011","journal-title":"Brain"},{"issue":"7","key":"10.1016\/j.neurobiolaging.2021.06.004_bib0007","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1001\/jamaneurol.2015.0606","article-title":"Clinical Features of Alzheimer Disease With and Without Lewy Bodies","volume":"72","author":"Chung","year":"2015","journal-title":"JAMA Neurol"},{"issue":"21","key":"10.1016\/j.neurobiolaging.2021.06.004_bib0008","doi-asserted-by":"crossref","first-page":"7281","DOI":"10.1523\/JNEUROSCI.0490-10.2010","article-title":"Synergistic Interactions between Abeta, tau, and alpha-synuclein: acceleration of neuropathology and cognitive decline","volume":"30","author":"Clinton","year":"2010","journal-title":"J Neurosci"},{"issue":"12","key":"10.1016\/j.neurobiolaging.2021.06.004_bib0009","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1097\/NEN.0000000000000018","article-title":"Confluence of alpha-synuclein, tau, and beta-amyloid pathologies in dementia with Lewy bodies","volume":"72","author":"Colom-Cadena","year":"2013","journal-title":"J Neuropathol Exp Neurol"},{"issue":"5123","key":"10.1016\/j.neurobiolaging.2021.06.004_bib0010","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1126\/science.8346443","article-title":"Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families","volume":"261","author":"Corder","year":"1993","journal-title":"Science (New York, N.Y.)"},{"issue":"529","key":"10.1016\/j.neurobiolaging.2021.06.004_bib0011","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aay3069","article-title":"APOE genotype regulates pathology and disease progression in synucleinopathy","volume":"12","author":"Davis","year":"2020","journal-title":"Sci Transl Med"},{"issue":"12","key":"10.1016\/j.neurobiolaging.2021.06.004_bib0012","doi-asserted-by":"crossref","first-page":"e1182","DOI":"10.1212\/WNL.0000000000006212","article-title":"<em>APOE<\/em>\u03b54 is associated with severity of Lewy body pathology independent of Alzheimer pathology","volume":"91","author":"Dickson","year":"2018","journal-title":"Neurology"},{"issue":"17","key":"10.1016\/j.neurobiolaging.2021.06.004_bib0013","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1212\/WNL.0b013e3181a2e8d0","article-title":"Effect of APOE genotype on amyloid plaque load and gray matter volume in Alzheimer disease","volume":"72","author":"Drzezga","year":"2009","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.neurobiolaging.2021.06.004_bib0014","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.jalz.2016.02.002","article-title":"Preclinical Alzheimer's disease: Definition, natural history, and diagnostic criteria","volume":"12","author":"Dubois","year":"2016","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.neurobiolaging.2021.06.004_bib0015","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.neulet.2016.02.042","article-title":"Effects of different isoforms of apoE on aggregation of the alpha-synuclein protein implicated in Parkinson's disease","volume":"618","author":"Emamzadeh","year":"2016","journal-title":"Neurosci Lett"},{"issue":"12","key":"10.1016\/j.neurobiolaging.2021.06.004_bib0016","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1002\/mds.21507","article-title":"Clinical diagnostic criteria for dementia associated with Parkinson's disease","volume":"22","author":"Emre","year":"2007","journal-title":"Mov Disord"},{"issue":"16","key":"10.1016\/j.neurobiolaging.2021.06.004_bib0017","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1001\/jama.1997.03550160069041","article-title":"Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium","volume":"278","author":"Farrer","year":"1997","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.neurobiolaging.2021.06.004_bib0018","doi-asserted-by":"crossref","first-page":"351","DOI":"10.2214\/ajr.149.2.351","article-title":"MR signal abnormalities at 1.5 T in Alzheimer's dementia and normal aging","volume":"149","author":"Fazekas","year":"1987","journal-title":"Am J Roentgenol"},{"issue":"3","key":"10.1016\/j.neurobiolaging.2021.06.004_bib0019","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1038\/nn2058","article-title":"A molecular pathway of neurodegeneration linking alpha-synuclein to ApoE and Abeta peptides","volume":"11","author":"Gallardo","year":"2008","journal-title":"Nat Neurosci"},{"issue":"6","key":"10.1016\/j.neurobiolaging.2021.06.004_bib0020","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1136\/jnnp.51.6.745","article-title":"The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease","volume":"51","author":"Gibb","year":"1988","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"12","key":"10.1016\/j.neurobiolaging.2021.06.004_bib0021","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1212\/01.wnl.0000326146.60732.d6","article-title":"Imaging amyloid deposition in Lewy body diseases","volume":"71","author":"Gomperts","year":"2008","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.neurobiolaging.2021.06.004_bib0022","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1111\/j.1750-3639.2000.tb00269.x","article-title":"Lewy bodies in Alzheimer's disease: a neuropathological review of 145 cases using alpha-synuclein immunohistochemistry","volume":"10","author":"Hamilton","year":"2000","journal-title":"Brain Pathol"},{"issue":"1","key":"10.1016\/j.neurobiolaging.2021.06.004_bib0023","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1212\/WNL.40.1.1","article-title":"The Lewy body variant of Alzheimer's disease: a clinical and pathologic entity","volume":"40","author":"Hansen","year":"1990","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2021.06.004_bib0024","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000007373","article-title":"Effects of Lewy body disease and Alzheimer disease on brain atrophy and cognitive dysfunction","author":"Kang","year":"2019","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.neurobiolaging.2021.06.004_bib0025","doi-asserted-by":"crossref","first-page":"e282","DOI":"10.1212\/WNL.0000000000008818","article-title":"\u03b2-Amyloid PET and neuropathology in dementia with Lewy bodies","volume":"94","author":"Kantarci","year":"2020","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.neurobiolaging.2021.06.004_bib0026","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1002\/mds.22858","article-title":"A comparison of gray and white matter density in patients with Parkinson's disease dementia and dementia with Lewy bodies using voxel-based morphometry","volume":"25","author":"Lee","year":"2010","journal-title":"Mov Disord"},{"key":"10.1016\/j.neurobiolaging.2021.06.004_bib0027","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.neurobiolaging.2018.08.007","article-title":"Amyloid-beta-related and unrelated cortical thinning in dementia with Lewy bodies","volume":"72","author":"Lee","year":"2018","journal-title":"Neurobiol Aging"},{"issue":"3","key":"10.1016\/j.neurobiolaging.2021.06.004_bib0028","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1002\/mds.24893","article-title":"Diagnostic criteria for mild cognitive impairment in Parkinson's disease: Movement Disorder Society Task Force guidelines","volume":"27","author":"Litvan","year":"2012","journal-title":"Mov Disord"},{"issue":"5","key":"10.1016\/j.neurobiolaging.2021.06.004_bib0029","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1212\/WNL.56.5.643","article-title":"Occipital hypoperfusion on SPECT in dementia with Lewy bodies but not AD","volume":"56","author":"Lobotesis","year":"2001","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.neurobiolaging.2021.06.004_bib0030","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/S1474-4422(07)70057-1","article-title":"Sensitivity and specificity of dopamine transporter imaging with 123I-FP-CIT SPECT in dementia with Lewy bodies: a phase III, multicentre study","volume":"6","author":"McKeith","year":"2007","journal-title":"Lancet Neurol"},{"issue":"1","key":"10.1016\/j.neurobiolaging.2021.06.004_bib0031","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1212\/WNL.0000000000004058","article-title":"Diagnosis and management of dementia with Lewy bodies: Fourth consensus report of the DLB Consortium","volume":"89","author":"McKeith","year":"2017","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.neurobiolaging.2021.06.004_bib0032","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.jalz.2011.03.005","article-title":"The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease","volume":"7","author":"McKhann","year":"2011","journal-title":"Alzheimers Dement"},{"issue":"19","key":"10.1016\/j.neurobiolaging.2021.06.004_bib0033","doi-asserted-by":"crossref","first-page":"e1807","DOI":"10.1212\/WNL.0000000000008377","article-title":"APOE\u03b54, white matter hyperintensities, and cognition in Alzheimer and Lewy body dementia","volume":"93","author":"Mirza","year":"2019","journal-title":"Neurology"},{"issue":"Pt 5","key":"10.1016\/j.neurobiolaging.2021.06.004_bib0034","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1093\/brain\/aww027","article-title":"Tau PET patterns mirror clinical and neuroanatomical variability in Alzheimer's disease","volume":"139","author":"Ossenkoppele","year":"2016","journal-title":"Brain"},{"issue":"6","key":"10.1016\/j.neurobiolaging.2021.06.004_bib0035","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1016\/j.jalz.2016.11.005","article-title":"Synergistic interaction between amyloid and tau predicts the progression to dementia","volume":"13","author":"Pascoal","year":"2017","journal-title":"Alzheimers Dement"},{"issue":"3","key":"10.1016\/j.neurobiolaging.2021.06.004_bib0036","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/j.neuroimage.2011.02.046","article-title":"A Bayesian model of shape and appearance for subcortical brain segmentation","volume":"56","author":"Patenaude","year":"2011","journal-title":"Neuroimage"},{"issue":"3","key":"10.1016\/j.neurobiolaging.2021.06.004_bib0037","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1001\/archneur.56.3.303","article-title":"Mild cognitive impairment: clinical characterization and outcome","volume":"56","author":"Petersen","year":"1999","journal-title":"Arch Neurol"},{"issue":"19","key":"10.1016\/j.neurobiolaging.2021.06.004_bib0038","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1056\/NEJM199511093331902","article-title":"Apolipoprotein E, dementia, and cortical deposition of beta-amyloid protein","volume":"333","author":"Polvikoski","year":"1995","journal-title":"New England J Med"},{"key":"10.1016\/j.neurobiolaging.2021.06.004_bib0039","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1016\/j.trci.2019.08.005","article-title":"Alzheimer's disease pathology explains association between dementia with Lewy bodies and APOE-epsilon4\/TOMM40 long poly-T repeat allele variants","volume":"5","author":"Prokopenko","year":"2019","journal-title":"Alzheimers Dement (N Y)"},{"issue":"7","key":"10.1016\/j.neurobiolaging.2021.06.004_bib0040","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1093\/brain\/awy146","article-title":"Neurodegenerative disease concomitant proteinopathies are prevalent, age-related and APOE4-associated","volume":"141","author":"Robinson","year":"2018","journal-title":"Brain: J Neurol"},{"issue":"5","key":"10.1016\/j.neurobiolaging.2021.06.004_bib0041","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1111\/nan.12294","article-title":"Cortical Lewy bodies and Abeta burden are associated with prevalence and timing of dementia in Lewy body diseases","volume":"42","author":"Ruffmann","year":"2016","journal-title":"Neuropathol Appl Neurobiol"},{"issue":"8","key":"10.1016\/j.neurobiolaging.2021.06.004_bib0042","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1016\/j.jalz.2015.02.004","article-title":"Florbetaben PET imaging to detect amyloid beta plaques in Alzheimer's disease: phase 3 study","volume":"11","author":"Sabri","year":"2015","journal-title":"Alzheimers Dement"},{"issue":"9","key":"10.1016\/j.neurobiolaging.2021.06.004_bib0043","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1016\/j.jalz.2018.04.005","article-title":"APOE-\u03b54 associates with hippocampal volume, learning, and memory across the spectrum of Alzheimer's disease and dementia with Lewy bodies","volume":"14","author":"Saeed","year":"2018","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.neurobiolaging.2021.06.004_bib0044","doi-asserted-by":"crossref","unstructured":"Strittmatter, W.J., Saunders, A.M., Goedert, M., Weisgraber, K.H., Dong, L.M., Jakes, R., Huang, D.Y., Pericak-Vance, M., Schmechel, D., Roses, A.D., 1994. Isoform-specific interactions of apolipoprotein E with microtubule-associated protein tau: implications for Alzheimer disease. Proc Natl Acad Sci U S A. 91(23), 11183-11186.","DOI":"10.1073\/pnas.91.23.11183"},{"issue":"4","key":"10.1016\/j.neurobiolaging.2021.06.004_bib0045","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1001\/jamaneurol.2019.4421","article-title":"Association of apolipoprotein E epsilon4 with medial temporal tau independent of amyloid-beta","volume":"77","author":"Therriault","year":"2020","journal-title":"JAMA Neurol"},{"issue":"2","key":"10.1016\/j.neurobiolaging.2021.06.004_bib0046","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1001\/jamaneurol.2013.600","article-title":"APOE epsilon4 increases risk for dementia in pure synucleinopathies","volume":"70","author":"Tsuang","year":"2013","journal-title":"JAMA Neurol"},{"issue":"6","key":"10.1016\/j.neurobiolaging.2021.06.004_bib0047","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1111\/j.1600-0404.2010.01362.x","article-title":"The role of APOE alleles in incident Parkinson's disease. The Norwegian ParkWest Study","volume":"122","author":"Vefring","year":"2010","journal-title":"Acta Neurol Scand"},{"issue":"8","key":"10.1016\/j.neurobiolaging.2021.06.004_bib0048","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1016\/j.jalz.2018.02.020","article-title":"Imaging correlations of tau, amyloid, metabolism, and atrophy in typical and atypical Alzheimer's disease","volume":"14","author":"Whitwell","year":"2018","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.neurobiolaging.2021.06.004_bib0049","doi-asserted-by":"crossref","unstructured":"Worsley, K.J., E. Taylor, J., Carbonell, F., Chung, M., Duerden, E., Bernhardt, B., Oc, L., Boucher, M., Evans, A., 2009. SurfStat: A Matlab toolbox for the statistical analysis of univariate and multivariate surface and volumetric data using linear mixed effects models and random field theory.","DOI":"10.1016\/S1053-8119(09)70882-1"},{"issue":"13","key":"10.1016\/j.neurobiolaging.2021.06.004_bib0050","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1212\/01.wnl.0000306697.48738.b6","article-title":"Patterns and stages of alpha-synucleinopathy: relevance in a population-based cohort","volume":"70","author":"Zaccai","year":"2008","journal-title":"Neurology"},{"issue":"529","key":"10.1016\/j.neurobiolaging.2021.06.004_bib0051","doi-asserted-by":"crossref","first-page":"eaay1809","DOI":"10.1126\/scitranslmed.aay1809","article-title":"APOE4 exacerbates alpha-synuclein pathology and related toxicity independent of amyloid","volume":"12","author":"Zhao","year":"2020","journal-title":"Sci Transl Med"}],"container-title":["Neurobiology of Aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197458021001949?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197458021001949?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T11:38:48Z","timestamp":1759318728000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0197458021001949"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":51,"alternative-id":["S0197458021001949"],"URL":"https:\/\/doi.org\/10.1016\/j.neurobiolaging.2021.06.004","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-100843\/v1","asserted-by":"object"}]},"ISSN":["0197-4580"],"issn-type":[{"value":"0197-4580","type":"print"}],"subject":[],"published":{"date-parts":[[2021,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Apolipoprotein E4, amyloid, and cognition in Alzheimer's and Lewy body disease","name":"articletitle","label":"Article Title"},{"value":"Neurobiology of Aging","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neurobiolaging.2021.06.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}